Problems of the Current Vaccination Strategy against Hepatitis B

Problems of the Current Vaccination Strategy against Hepatitis B

Accumulation of escape mutants of hepatitis B virus (HBV) occur in the many countries at the conditions of wide-scale vaccination against hepatitis B, especially among vaccinated children. The real prevalence of such mutants is underestimated and the capacity of current vaccines to provide cross-imm...

Full description

Bibliographic Details
Main Authors:	M. V. Konopleva, V. N. Borisova, T. A. Semenenko, M. A. Krymskij
Format:	Article
Language:	Russian
Published:	Numikom LLC 2017-08-01
Series:	Эпидемиология и вакцинопрофилактика
Subjects:	вирус гепатита в вакцина антиген мутация g145r рекомбинантный и нативный hbsag иммунизация problems of the current vaccination strategy against hepatitis b hepatitis b virus hbv vaccine antigen mutation s143l вгв recombinant and native hbsag immunization
Online Access:	https://www.epidemvac.ru/jour/article/view/296

Similar Items

Characterization of Occult Hepatitis B Virus Infection in HIV-Positive Individuals
by: Martin Quigley, Christina M.
Published: (2011)

HEPATITIS B IN PREGNANCY – MODERN APPROACHES TO SCREENING AND PREVENTION OF VERTICAL TRANSMISSION OF INFECTION
by: Кира Борисовна Мозес, et al.
Published: (2019-10-01)

The prevalence of parenteral hepatitis markers among the medical personnel in the Russian Federation regions with different intensity of epidemic process
by: Nikitina G.Yu., et al.
Published: (2017-05-01)

[Use of tenofovir monotherapy in a cohort of prisoners confined in the prisons of the Molise region and affected by mild HBV-related chronic hepatitis]
by: Roberto Patriarchi, et al.
Published: (2015-12-01)

Protection against hepatitis B by the Butang® recombinant vaccine in newborn children in South Brazil
by: Aline Paula Isolani, et al.
Published: (2006-08-01)

ANTIBODY TITER AGAINST HBSAGIN CHILDREN ENTERING ELEMENTARY SCHOOL WHO WERE VACCINATED AGAINST HEPATITIS B AT BIRTH: SBAHR.E.KORD CITY
by: K MOSTAFAVIZADEH, et al.
Published: (2001-09-01)

Anti-Hepatitis B Antibody Levels In Immunized Medical Students: Are They At Risk?
by: Keila Zaniboni Siqueira Batista, et al.
Published: (2019-05-01)

Surface protein mutations in chronic hepatitis B patients who received hepatitis B vaccine therapy
by: Maryam Daram, et al.
Published: (2014-09-01)

Use of Modern molecular Genetic Methods to Study Genetic Diversity of Hepatitis B Strains on the Territory of Khabarovsk City
by: V. O. Kotova, et al.
Published: (2016-04-01)

Vaccination Effect on Epidemic Process of Viral Hepatitis B In Republic of Belarus
by: V. S. Vysotskaya, et al.
Published: (2019-03-01)

Characterization of a Hepatitis B virus strain in southwestern Paraná, Brazil, presenting mutations previously associated with anti-HBs Resistance Caracterização de uma cepa de hepatite por vírus B no sudoeste do Paraná, Brasil, apresentando mutações previamente associadas à resistência anti-HBs
by: Dennis Armando Bertolini, et al.
Published: (2010-02-01)

Is Quantitative HBsAg Measurement a Reliable Substitute for HBV DNA Quantitation?
by: Mohammad Reza Mahdavi, et al.
Published: (2015-07-01)

A retrospective serological survey of hepatitis B virus infection in Northeast China
by: Jing Meng, et al.
Published: (2019-05-01)

The relationship between polymorphisms in intron 8 of vitamin D receptor gene and occult HBV infection
by: Rezvani ME, et al.
Published: (2009-08-01)

Detection of Mediterranean Hepatitis B in a 45 Years Old Man in Mahdieh Clinical Laboratory, Isfahan, Iran
by: Majid Komijani, et al.
Published: (2017-09-01)

Change of HBsAg Screening and Seropositivity in Pregnant Women By the Years
by: Gökhan TOSUN, et al.
Published: (2019-12-01)

A comparison on HBsAg and HBsAb prevalence in patients with Down syndrome and other mentally retarded patients living in retarded children institutes in Tehran
by: Sahebjamei M. Associate Professor, et al.
Published: (2003-06-01)

How immigration can change the prevalence of HBV infection in an urban area of Northern Italy
by: Massimo De Paschale, et al.
Published: (2011-11-01)

Comparative analysis of the safety and efficacy of HBsAg-1018 versus HBsAg-Eng: a meta-analysis
by: Lin Zhang, et al.
Published: (2020-01-01)

Elimination of Hepatitis B in Highly Endemic Settings: Lessons Learned in Taiwan and Challenges Ahead
by: Chun-Jen Liu, et al.
Published: (2020-07-01)

СОЧЕТАННЫЕ ВИРУСНЫЕ ИНФЕКЦИИ У ПАЦИЕНТОВ С ХРОНИЧЕСКИМ ГЕПАТИТОМ В: РАСПРОСТРАНЕННОСТЬ И КЛИНИЧЕСКОЕ ЗНАЧЕНИЕ
by: D. V. Tserashkou, et al.
Published: (2021-01-01)

Epidemiology screening and genotyping analysis for Hepatitis B virus in Southwestern region of Saudi Arabia
by: Alkhansa Alshabi, et al.
Published: (2021-02-01)

The Pigeonhole of Occult Hepatitis B
by: Payam Dindoost, et al.
Published: (2014-08-01)

A chronic hepatitis B patient infected with HBsAg diagnostic-escape strain in the presence of anti-HBs positivity
by: Aydemir Serkan, et al.
Published: (2019-10-01)

Evaluation of miR-143 and miR-145 Expression in Tumors and Tumor Margins in Patients with Colorectal Cancer
by: Shabnam Vardini, et al.
Published: (2017-12-01)

Prevalence of Hepatitis D Among Patients with Hepatitis B Viral Infection Attending a Tertiary Care Centre of Nepal
by: Kiran Regmi, et al.
Published: (2017-12-01)

Long-Term Follow-Up of Acute Hepatitis B: New Insights in Its Natural History and Implications for Antiviral Treatment
by: Stefano Menzo, et al.
Published: (2018-06-01)

The Role of Body Fluids in the Horizontal Transmission of Hepatitis B Virus via Household Close Contact
by: Haruki Komatsu, et al.
Published: (2016-01-01)

Clinical and laboratory characteristics of occult hepatitis B
by: E. V. Esaulenko, et al.
Published: (2016-04-01)

Analysis of long non-coding RNA (lncRNA) expression in hepatitis B patients
by: Sunde Yılmaz Susluer, et al.
Published: (2018-05-01)

Seroprevalence of Hepatitis B virus Infection by Quantitative Chemiluminescent in Tabriz (North West of Iran), 2010-2011
by: Nader Hajizadeh, et al.
Published: (2014-08-01)

Protracted HBsAg-aemia in a Patient with Acute Hepatitis B
by: K. R. Dudina, et al.
Published: (2018-11-01)

A Therapeutic Hepatitis B Virus DNA Vaccine Induces Specific Immune Responses in Mice and Non-Human Primates
by: Dorien De Pooter, et al.
Published: (2021-08-01)

Combination of Entecavir or Tenofovir with Pegylated Interferon-α for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy
by: Kanako Yoshida, et al.
Published: (2021-02-01)

Response predictors to treatment with pegylated interferon in chronic hepatitis B
by: Paulo Roberto Abrão Ferreira, et al.

The association of vitamin D with hepatitis B virus replication: Bystander rather than offender
by: Chia-Chi Wang, et al.
Published: (2020-11-01)

Prevalence of HBV genotypes in South American immigrants affected by HBV-related chronic active hepatitis
by: Emilio Palumbo, et al.

Evaluation of serum level of IL-12 in patients with
by: Mohammad Kazemi Arababadi1, et al.
Published: (2009-01-01)

Hepatitis B virus exposure in human immunodeficiency virus seropositive Cuban patients
by: Licel Rodríguez, et al.
Published: (2000-04-01)

Response of Preterm Infants of Mothers Who Are Chronic Carriers of Both HBsAg and HBeAg to Pre-52 Containing Hepatitis 8 Vaccine (TGP 943) - A Preliminary Report
by: Abdul Hamid Sutohardjo
Published: (2018-10-01)